Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,483.60
-17.00 (-0.68%)
At close: Oct 28, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.03 trillion as of October 28, 2026. Its market cap has increased by 3.10% in one year.
Market Cap
1.03T
Enterprise Value
1.06T
Revenue
153.79B
Global Rank
n/a
Country Rank
n/a
PE Ratio
45.79
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.03T, an increase of 80.51%. That is a compound annual growth rate of 18.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 1.03T | 13.43% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.40T |
| Zydus Lifesciences | 1.16T |
| Laurus Labs | 1.11T |
| Cipla | 1.09T |
| Mankind Pharma | 954.85B |
| Aurobindo Pharma | 914.85B |
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |